ArticleJournal of arrhythmia2026
REgistry Of Catheter AbLation After Congenital Heart Disease Surgery(REAL-CHD Registry).
Article in Journal of arrhythmia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
34 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Advances in surgical management have improved long-term survival in patients with congenital heart disease (CHD), leading to a growing population of adults with postoperative arrhythmias. However, contemporary data on catheter ablation practice and outcomes in patients with CHD remain limited. Methods: This multicenter, retrospective registry study included patients who underwent catheter ablation for postoperative CHD-related arrhythmias between April 2007 and December 2025 at 10 centers. CHD severity was classified as mild, moderate, or severe according to Japanese Circulation Society guidelines. Procedural characteristics, arrhythmia profiles, acute procedural outcomes, and complications were analyzed. Associations between age, disease severity, arrhythmia burden, and procedural success were evaluated using regression analyses. Results: A total of 1 719 patients were included. The number of ablation procedures increased over time across all CHD severity categories. Increasing age was associated with lower disease severity, whereas patients with severe CHD, particularly those after a Fontan repair, underwent ablation at younger ages. Procedural success decreased with increasing CHD severity (complete success: 92.5% in mild, 81.4% in moderate, and 71.4% in severe CHD) and with a greater number of induced arrhythmia types. Overall, procedure-related complications occurred in 2.3% of patients, with worsening heart failure being the most frequent non-vascular adverse event. Conclusion: In a large contemporary Japanese cohort, catheter ablation for postoperative CHD-related arrhythmias was increasingly performed and demonstrated acceptable safety. However, procedural success was lower in patients with more severe CHD and greater arrhythmia complexity, highlighting the need for specialized ablation strategies and careful periprocedural management in this growing population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.